BLUECROSS Trademark

Trademark Overview


On Sunday, August 10, 2014, a trademark application was filed for BLUECROSS with the United States Patent and Trademark Office. The USPTO has given the BLUECROSS trademark a serial number of 86362183. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, July 30, 2025. This trademark is owned by BLUE CROSS BIO-MEDICAL (BEIJING) CO., LTD.. The BLUECROSS trademark is filed in the Pharmaceutical Products category with the following description:

[ Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Blood plasma; Chemical preparations for sanitary purposes; Chemical reagents for medical or veterinary purposes; ] Diagnostic preparations for medical purposes; [ Medicated serums for treatment of hair, skin lips; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceu...
bluecross

General Information


Serial Number86362183
Word MarkBLUECROSS
Filing DateSunday, August 10, 2014
Status800 - REGISTERED AND RENEWED
Status DateWednesday, July 30, 2025
Registration Number4708055
Registration DateTuesday, March 24, 2015
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 6, 2015

Trademark Statements


Description of MarkThe mark consists of stylized wording "BlueCROSS".
Goods and Services[ Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Blood plasma; Chemical preparations for sanitary purposes; Chemical reagents for medical or veterinary purposes; ] Diagnostic preparations for medical purposes; [ Medicated serums for treatment of hair, skin lips; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical preparations, namely, injectable contraceptives; ] Pregnancy test kits for home use
Pseudo MarkBLUE CROSS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 19, 2014
Primary Code005
First Use Anywhere DateTuesday, January 1, 2008
First Use In Commerce DateTuesday, January 1, 2008

Trademark Owner History


Party NameBLUE CROSS BIO-MEDICAL (BEIJING) CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChangping, Beijing 102209
CN

Party NameBLUE CROSS BIO-MEDICAL (BEIJING) CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChangping, Beijing 102209
CN

Party NameBLUE CROSS BIO-MEDICAL (BEIJING) CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChangping, Beijing 102209
CN

Trademark Events


Event DateEvent Description
Wednesday, August 20, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, December 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 6, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, March 24, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sunday, May 17, 2020TEAS SECTION 8 RECEIVED
Thursday, August 6, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 7, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, August 13, 2014NEW APPLICATION ENTERED
Tuesday, August 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 24, 2014ASSIGNED TO EXAMINER
Monday, November 24, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 6, 2015PUBLISHED FOR OPPOSITION
Friday, August 7, 2020NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Wednesday, March 5, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 5, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, March 5, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 5, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 24, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, March 6, 2025TEAS SECTION 8 & 9 RECEIVED
Monday, July 28, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 30, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, July 30, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, July 30, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED